Cargando…
Special Issue: Antifungal Agents Recently Approved or under Development
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004745/ https://www.ncbi.nlm.nih.gov/pubmed/33806755 http://dx.doi.org/10.3390/jof7030239 |
_version_ | 1783671973498322944 |
---|---|
author | Espinel-Ingroff, Ana Dannaoui, Eric |
author_facet | Espinel-Ingroff, Ana Dannaoui, Eric |
author_sort | Espinel-Ingroff, Ana |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8004745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80047452021-03-29 Special Issue: Antifungal Agents Recently Approved or under Development Espinel-Ingroff, Ana Dannaoui, Eric J Fungi (Basel) Editorial MDPI 2021-03-23 /pmc/articles/PMC8004745/ /pubmed/33806755 http://dx.doi.org/10.3390/jof7030239 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Editorial Espinel-Ingroff, Ana Dannaoui, Eric Special Issue: Antifungal Agents Recently Approved or under Development |
title | Special Issue: Antifungal Agents Recently Approved or under Development |
title_full | Special Issue: Antifungal Agents Recently Approved or under Development |
title_fullStr | Special Issue: Antifungal Agents Recently Approved or under Development |
title_full_unstemmed | Special Issue: Antifungal Agents Recently Approved or under Development |
title_short | Special Issue: Antifungal Agents Recently Approved or under Development |
title_sort | special issue: antifungal agents recently approved or under development |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004745/ https://www.ncbi.nlm.nih.gov/pubmed/33806755 http://dx.doi.org/10.3390/jof7030239 |
work_keys_str_mv | AT espinelingroffana specialissueantifungalagentsrecentlyapprovedorunderdevelopment AT dannaouieric specialissueantifungalagentsrecentlyapprovedorunderdevelopment |